文献速递眼底病与葡萄膜炎神经眼科

慢性肾功能不全队列研究中视网膜病变进展与心血管疾病发病的关联

Progression of retinopathy and incidence of cardiovascular disease: findings from the Chronic Renal Insufficiency Cohort Study.
PubMed 文献 · Br J Ophthalmol · 2020-06-05

该研究基于慢性肾功能不全队列研究,评估基线无视网膜病变的慢性肾脏病(CKD)患者视网膜病变进展与心血管疾病(CVD)事件发生的关联。平均间隔3.5年两次眼底照相,9.8%患者视网膜病变进展≥2级(EDTRS分级),校正CVD和CKD危险因素后与CVD事件风险增加相关(OR 2.56,95%CI 1.25-5.22,p<0.01)。

要点

  • CKD患者视网膜病变进展(EDTRS分级≥2级)与CVD事件风险增加独立相关。
  • 校正CKD和CVD危险因素后,视网膜病变进展者CVD风险OR为2.56(95%CI 1.25-5.22,p<0.01)。
  • 视网膜形态学评估可能为CKD患者CVD风险评估提供额外信息。

核心结论

  • 视网膜病变进展与CKD患者CVD事件发生率升高相关,视网膜血管病变可能提示大血管疾病。

研究设计与样本

  • 慢性肾功能不全队列研究(CRIC)中,1936名受邀参与者中1051名在平均间隔3.5年的两个时间点接受眼底照相。
  • 由不知晓参与者信息的培训评级员在视网膜图像阅读中心评估视网膜病变(糖尿病性、高血压性或其他)及血管直径。
  • 排除自报CVD病史者,CVD事件由医师根据病历和标准化标准裁定。

主要发现

  • 9.8%的参与者出现EDTRS视网膜病变分级量表进展≥2级。
  • 校正其他CVD和CKD危险因素后,视网膜病变进展与任何CVD事件风险增加相关(OR 2.56,95%CI 1.25-5.22,p<0.01)。
  • 缺失数据插补后,OR=1.66(95%CI 0.87-3.16),p=0.12。

关键数值与推荐

  • 视网膜病变进展定义为EDTRS视网膜病变分级量表进展≥2级。
  • CVD事件由医师根据病历和标准化标准裁定。

临床怎么用

  • 对CKD患者,视网膜形态学评估可能有助于识别CVD高风险个体。
  • 视网膜病变进展可作为CKD患者大血管疾病的潜在指示标志。

局限性

  • 缺失数据插补后关联不再显著(OR 1.66,95%CI 0.87-3.16,p=0.12),提示结果需谨慎解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Chronic kidney disease (CKD) patients often develop cardiovascular disease (CVD) and retinopathy. The purpose of this study was to assess the association between progression of retinopathy and concurrent incidence of CVD events in participants with CKD. DESIGN: We assessed 1051 out of 1936 participants in the Chronic Renal Insufficiency Cohort Study that were invited to have fundus photographs obtained at two timepoints separated by 3.5 years, on average. METHODS: Using standard protocols, presence and severity of retinopathy (diabetic, hypertensive or other) and vessel diameter calibre were assessed at a retinal image reading centre by trained graders masked to study participants' information. Participants with a self-reported history of CVD were excluded. Incident CVD events were physician adjudicated using medical records and standardised criteria. Kidney function and proteinuria measurements along with CVD risk factors were obtained at study visits. RESULTS: Worsening of retinopathy by two or more steps in the EDTRS retinopathy grading scale was observed in 9.8% of participants, and was associated with increased risk of incidence of any CVD in analysis adjusting for other CVD and CKD risk factors (OR 2.56, 95% CI 1.25 to 5.22, p<0.01). After imputation of missing data, these values were OR=1.66 (0.87 to 3.16), p=0.12. CONCLUSION: Progression of retinopathy is associated with higher incidence of CVD events, and retinal-vascular pathology may be indicative of macrovascular disease even after adjustment for kidney diseases and CVD risk factors. Assessment of retinal morphology may provide important information when assessing CVD in patients with CKD.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Grunwald JE, Pistilli M, Ying GS, et al. Progression of retinopathy and incidence of cardiovascular disease: findings from the Chronic Renal Insufficiency Cohort Study. Br J Ophthalmol. 2020. PMID: 32503932. doi:10.1136/bjophthalmol-2019-315333

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。